Mr Steven C Desousa, PT - Medicare Physical Therapist in East Northport, NY

Mr Steven C Desousa, PT is a medicare enrolled "Physical Therapist" provider in East Northport, New York. He graduated from medical school in 2006 and has 18 years of diverse experience with area of expertise as Physical Therapy. He is a member of the group practice Steven C. Desousa, Pt, Pc and his current practice location is 554 Larkfield Rd, Suite 207, East Northport, New York. You can reach out to his office (for appointments etc.) via phone at (631) 266-4501.

Mr Steven C Desousa is licensed to practice in New York (license number 0138961) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1457321911.

Contact Information

Mr Steven C Desousa, PT
554 Larkfield Rd, Suite 207,
East Northport, NY 11731-4205
(631) 266-4501
(631) 266-4502



Healthcare Provider's Profile

Full NameMr Steven C Desousa
GenderMale
SpecialityPhysical Therapy
Experience18 Years
Location554 Larkfield Rd, East Northport, New York
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mr Steven C Desousa graduated from medical school in 2006
  NPI Data:
  • NPI Number: 1457321911
  • Provider Enumeration Date: 01/25/2006
  • Last Update Date: 03/18/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 8325122609
  • Enrollment ID: I20080226000132

Medical Identifiers

Medical identifiers for Mr Steven C Desousa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457321911NPI-NPPES
AZ00899OtherMDNY PROVIDER ID
6699926OtherGHI PROVIDER ID
01914598MedicaidNY
Q38811OtherBC BS PROVIDER ID
54388OtherVYTRA ID
A2517039OtherOXFORD PROVIDER ID

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 0138961 (New York)Primary
2251H1200XPhysical Therapist - Hand 0138961 (New York)Secondary
2251S0007XPhysical Therapist - Sports 0138961 (New York)Secondary
2251X0800XPhysical Therapist - Orthopedic 0138961 (New York)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Steven C. Desousa, Pt, Pc22645179452

News Archive

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

Researchers working on full-page Braille display system to help blind read better

Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.

Love hormone oxytocin linked to hypersexuality

Sex addiction or hypersexual disorder is a behavior characterized by an excessive preoccupation with sexual fantasies, behaviors, or urges that are hard to control, causing negative effects on one's health and relationships.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Steven C Desousa allows following entities to bill medicare on his behalf.
Provider NameSteven C. Desousa, Pt, Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1487786158
PECOS PAC ID: 2264517945
Enrollment ID: O20080305000077

News Archive

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

Researchers working on full-page Braille display system to help blind read better

Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.

Love hormone oxytocin linked to hypersexuality

Sex addiction or hypersexual disorder is a behavior characterized by an excessive preoccupation with sexual fantasies, behaviors, or urges that are hard to control, causing negative effects on one's health and relationships.

Read more Medical News

› Verified 2 days ago

Provider NameProvident Physical And Occupational Therapy Pllc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1144742479
PECOS PAC ID: 5395006167
Enrollment ID: O20180220000364

News Archive

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

Researchers working on full-page Braille display system to help blind read better

Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.

Love hormone oxytocin linked to hypersexuality

Sex addiction or hypersexual disorder is a behavior characterized by an excessive preoccupation with sexual fantasies, behaviors, or urges that are hard to control, causing negative effects on one's health and relationships.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Steven C Desousa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr Steven C Desousa, PT
554 Larkfield Rd, Suite 207,
East Northport, NY 11731-4205

Ph: (631) 266-4501
Mr Steven C Desousa, PT
554 Larkfield Rd, Suite 207,
East Northport, NY 11731-4205

Ph: (631) 266-4501

News Archive

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

Researchers working on full-page Braille display system to help blind read better

Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.

Love hormone oxytocin linked to hypersexuality

Sex addiction or hypersexual disorder is a behavior characterized by an excessive preoccupation with sexual fantasies, behaviors, or urges that are hard to control, causing negative effects on one's health and relationships.

Read more News

› Verified 2 days ago


Physical Therapist in East Northport, NY

Joseph Kleynowski, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 279 Larkfield Rd, East Northport, NY 11731
Phone: 631-262-1370    Fax: 631-262-0415
Amy Piacentini, PT
Physical Therapist
Medicare: May Accept Medicare Assignments
Practice Location: 5 Alister Cir, East Northport, NY 11731
Phone: 631-543-7771    
Paul Henry Vazquez, M.S., P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 457 Clay Pitts Rd, East Northport, NY 11731
Phone: 631-486-8572    Fax: 631-368-4975
Ms. Kathleen C Fruehsamer, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 19 Wood Sorrell Ln, East Northport, NY 11731
Phone: 631-368-8009    
Provident Physical And Occupational Therapy Pllc
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 554 Larkfield Rd Ste 207, East Northport, NY 11731
Phone: 631-266-4501    Fax: 631-266-4502
Emily Connolly,
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 9a Hewitt Sq, East Northport, NY 11731
Phone: 631-721-9530    
Graceanne Lopez,
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 3072 Jericho Tpke, East Northport, NY 11731
Phone: 631-462-9595    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.